Argus Investors' Counsel, Inc. Boston Scientific Corp Transaction History
Argus Investors' Counsel, Inc.
- $126 Million
- Q1 2025
A detailed history of Argus Investors' Counsel, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 26,448 shares of BSX stock, worth $2.49 Million. This represents 2.12% of its overall portfolio holdings.
Number of Shares
26,448
Previous 26,352
0.36%
Holding current value
$2.49 Million
Previous $2.35 Million
13.39%
% of portfolio
2.12%
Previous 1.63%
Shares
5 transactions
Others Institutions Holding BSX
# of Institutions
1,704Shares Held
1.19BCall Options Held
8.76MPut Options Held
9.43M-
Vanguard Group Inc Valley Forge, PA133MShares$12.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.9 Billion0.22% of portfolio
-
State Street Corp Boston, MA64MShares$6.03 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.48 Billion2.61% of portfolio
-
Geode Capital Management, LLC Boston, MA30.6MShares$2.89 Billion0.22% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $135B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...